Skip to main content
PYC THERAPEUTICS LIMITED logo

PYC THERAPEUTICS LIMITED — Investor Relations & Filings

Ticker · PYC ISIN · AU000000PYC7 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,297 across all filing types
Latest filing 2023-06-05 Investor Presentation
Country AU Australia
Listing ASX PYC

About PYC THERAPEUTICS LIMITED

https://pyctx.com/

PYC Therapeutics Limited is a clinical-stage company focused on developing precision medicines for patients with rare genetic diseases. The company utilizes a proprietary drug delivery platform that combines naturally derived cell-penetrating peptides with antisense oligonucleotides to create RNA-based therapeutics. This platform is designed to overcome the challenges of delivering large therapeutic molecules into target cells, particularly within the eye and central nervous system. PYC's primary pipeline includes VP-001, a candidate for Retinitis Pigmentosa type 11, and PYC-001, targeting Autosomal Dominant Optic Atrophy. Additionally, the company is advancing programs for Polycystic Kidney Disease. By leveraging its delivery technology, PYC aims to address the underlying genetic causes of diseases that currently lack effective treatment options.

Recent filings

Filing Released Lang Actions
Phelan-McDermid Syndrome & CNS platform presentation 15 pages 937.9KB
Investor Presentation Classification · 95% confidence The document is a detailed presentation of PYC Therapeutics' Phelan-McDermid Syndrome program, including scientific data, drug candidate information, clinical development plans, and business development context. It is explicitly described as presentation materials for the BIO 2023 conference, a major industry event. The content includes slides, scientific figures, and forward-looking statements typical of investor or industry presentations. There is no indication that this is a formal regulatory filing, annual or interim report, earnings release, or other official financial document. The document is not a brief announcement or a certification but a comprehensive presentation aimed at investors and partners. Therefore, the document best fits the category of an Investor Presentation (IP).
2023-06-05 English
Notice of General Meeting/Proxy Form 19 pages 994.3KB
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Notice of General Meeting for PYC Therapeutics Limited, detailing the agenda for shareholder resolutions related to ratification and approval of share issues under a placement. It includes proxy voting instructions, meeting details, and an explanatory memorandum about the placement and use of funds. The content focuses on shareholder meeting logistics and resolutions rather than financial results or management discussion. It is not an Annual Report, Earnings Release, or Management Report. It is not a proxy solicitation statement but a Notice of General Meeting with accompanying explanatory information. The primary purpose is to notify shareholders of the meeting and the resolutions to be voted on, which fits the definition of a Proxy Solicitation & Information Statement (PSI). The document length and detail also support this classification rather than a brief announcement or a full report.
2023-06-01 English
Appointment of Joint Company Secretary 1 page 188.5
Board/Management Information Classification · 100% confidence The document announces the appointment of a new joint Company Secretary, detailing the individual's qualifications and effective date. It is a corporate governance-related announcement about a change in senior management. There are no financial statements, audit information, or report publications. The content fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2023-05-31 English
Ceasing to be a substantial holder 2 pages 291.3KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 605 filed under the Corporations Act 2001, titled 'Notice of ceasing to be a substantial holder.' It details changes in relevant interests and voting securities of a substantial shareholder, Bernard Hockings, including dates and nature of changes. This form is a regulatory notification about shareholding changes, specifically about ceasing to be a substantial holder, which fits the definition of a Major Shareholding Notification. The document is not a financial report, earnings release, or management report, but a formal notification of shareholding status changes as required by law.
2023-05-21 English
Ceasing to be a substantial holder 1 page 100.5KB
Major Shareholding Notification Classification · 95% confidence The document is a Form 605 Notice of ceasing to be a substantial holder under the Corporations Act 2001 Section 671B. It details changes in substantial shareholding, including dates, nature of changes, and voting securities affected. This type of filing is a notification of changes in significant share ownership levels, which corresponds to the category Major Shareholding Notification (MRQ). The document length is short and focused solely on shareholding changes, with no financial statements or other report content. Therefore, it fits the MRQ category with high confidence.
2023-05-21 English
Application for quotation of securities - PYC 6 pages 27.9KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Application for quotation of +securities' and details the application for quotation of securities on the ASX (Australian Securities Exchange). It includes information about the entity, the securities to be quoted, issue dates, distribution schedules, and issued capital following quotation. There is no financial performance data, earnings information, or management discussion. The document is an announcement related to the listing or quotation of securities rather than a financial report or earnings release. This fits the category of Share Issue/Capital Change (SHA), which covers announcements regarding new share issues or capital changes.
2023-05-18 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.